chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had flu vaccine and pneumonia vaccine 12/10/07. Received call on 12/11/07 said pts arm was very red and slightly swollen where the vaccine given warm to touch. Pt says slightly painful. Redness extends from elbow to shoulder.
3:05 Presented for Moderna Covid Vaccine-1st Dose 3:15 Moderna Lot# 020B21A given in the R deltoid given 3:36 Began to have ? scratchy throat and racing heart 3:36 O2 sat 97% and HR 84-will continue to monitor for an additional 15 minutes. No history of anaphylaxis reported. 4:00 ? non radiating chest pain. Described as a ?hard? feeling in center of sternum. No diaphoresis or shortness of breath observed, No LOC.  BP 180/94 4:05 EMS called 4:15 EMS arrived. BP 195/125. EKG w/ occasional PVC. O2 sat remains in upper 90?s 4:35 Transported to ER
Approximately 0925 pt returned to tx area, stating he was itching, feeling anxious. Pt appeared anxious, skin cool/dry. 0930 BENADRYL 25mg PO given with pt. VS=144/86 72 - eupneic. Denies difficulty breathing. Pt observed fluids given orally. 1015 131/87 71 - eupneic. Pt reports symptoms resolved now with c/o headache Release to who states he will get SM.
flu like sx, h/a, fever, aching back & legs; fever for 3 days (101); aching for 4-5 days;
I started with a scratchy throat and a cough. I also had sinus congestion. It continued to get into my chest causing more coughing and shortness of breath. I began initially taking over the counter sinus spray and decongestion but that did not help. I contacted my doctor after completing a COVID-19  Home test on May 25, 2022. I was prescribed Paxlovid. Within a day of taking the medicine I started to feel better.  It took about 3 days for everything to go back to normal. I continued testing until I was negative on June 01, 2022. I got it the first time after traveling. My spouse contracted it about 2 weeks later. I started coming down with symptoms again on June 27th. I started again to have a scratchy throat, sinus congestion and this time the cough was worse. By Wednesday June 29th, I was having difficulty breathing so the doctor recommended that I do the monoclonal antibody infusion since I I tested positive on June 29th. After having the infusion I started to feel better within a few hours. I finally tested negative on July 03rd. I went to the doctor today because I still have a lingering cough.
stroke; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female non-pregnant patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in arm left on 16Apr2021 12:00 (batch/lot number: ER8737) at 58 years of age as dose 2, single for covid-19 immunisation at a public health clinic/veterans administration facility. Medical history included hypothyroidism, cervical spine fusion, PFO (patent foramen ovale), allergy. The patient, prior to vaccination, was not diagnosed with COVID-19. Concomitant medications included unspecified medications. The patient received other medications within 2 weeks of vaccination. The patient previously took dose 1 of BNT162B2 administered in the left arm on 26Mar2021 13:30 (batch/lot number EP7534) at 58 years of age for Covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Jul2021 08:00, the patient experienced stroke. The reporter informed that the event was serious - hospitalization for 4 days. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient, since the vaccination, has been tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): negative   on 17Sep2021, testing with unknown results on unspecified date. The patient received unspecified medications as treatment for the event. The outcome of the event was recovered on unspecified date in 2021.
After receiving the vaccine patient felt lightheaded and had itchy throat. The pharmacist observed the patient for 30 minutes. Patient was given Diphenhydramine 25 mg tab, since patient did not want to take the liquid form. Patient felt better within a few minutes. Patient was observed by pharmacist until she felt well to leave. Patient was accompanied by her husband. Patient did not require or want for ambulance to be called. Patient was advised to seek medical attention and head to ER for any potential secondary reactions. Patient was also advised to follow up with her primary care provider.  Contacted the patient on 7/20/22 at 11am. reported feeling well without any additional reactions.
Received Hep A and 2nd week on 10/18/03-was sl. fussy pm of 10/18 and call of 10/19-10/20/03 woke up with fever. Temp at office visit 104.5. 10/24/03 attempted to call home # for status check-number was disconnected.
rash started after each moderna covid-19 vaccine.  it continues to come and goes months later.
1500: Pt answered immunization screening questions, received the covid vaccine, waited the recommended 15 minutes post vaccine and left the facility.  1530:  Pt returned to the vaccine hub indicating that while she was driving in heavy traffic, she experienced pain to the nape of her neck and indicated that she was "swallowing hard" and felt the need to come back.  Pt appeared flushed, was speaking rapidly, and tachypnea noted .  Writer encouraged pt to sit in chair and focus on breathing deeply in through her nose and out through her mouth.  1535:  BP 132/71, HR 92.  1540:  BP 130/76, HR 88, RR 22 and unlabored.  Pt given bottle of water and encouraged to continue to focus on breathing.  Writer verified the allergy of garlic listed was indeed the only know allergy.  Pt agreed and indicated she "takes alot of child dose of benadryl for environmental/seasonal issues".  1600:  BP 127/74, HR 84, RR 18, even and unlabored. Pt states she was feeling much better.  Writer informed pt to present to ED if the problem recurred and to follow up with PCP.  Pt voiced understanding.
Pt recvd vax 15JUL92 AM around 10AM-215PM mom called stated t102.2 ax & pt had given APAP; irritable;
Pt. woke up at 4 AM with hives to the ear, neck, face. She went to the urgent care at 3:30 PM. They started her on Prednisone. The hives cleared up somewhat then came back in a different area of the body. Pt. went to urgent care. They prescribed prednisone, and ranitidine. Pt. still having symptoms and has an appointment with an allergist on 10/31/17.
Rt deltoid red and warm to touch. Received IPV and DTAP in area on 6/1/06. Localized reaction. Keflex and Benadryl given.
This spontaneous report was received from a registered nurse and refers to a 12 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The stock of vaccine was received on 11-OCT-2016. On 13-JAN-2017, the patient was vaccinated with an improperly stored dose of PROQUAD, lot # M023931 with expiration date of 09-NOV-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 33 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1705USA013888.
SEVERE FEVER OVER 103 FOR 2 + DAYS, FULL BODY RASH, DIZZINESS, NAUSEA, HEADACHES, VOMITING
11-13-17 brief episode of severe vertigo, then on 11-14-17 at 1045am had another episode of severe vertigo- patient went to emergency room that evening and got admitted for two nights, patient has not been symptom free yet. Patient's vertigo has decreased over the past month however not completely resolved- treatment has included physical therapy and meclizine, MD is also trying KLONOPIN. Patient currently not able to drive due to vertigo and effects daily movements.
Feeling weak, no energy; Muscle aches; Fatigue; Muscle weakness; I got HDV /I have got blood clot on my leg; This is a spontaneous report from contactable consumer (patient) from a Pfizer Sponsored Program. A 73-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FA7485), via intramuscular route administered in left arm on 29Jul2021 (at the age of 73-years-old) as dose 1, single for COVID-19 immunization. Medical history included Blood clot in leg. Concomitant medications included rivaroxaban (XARELTO) 5mg, once in a day, oral taken for Blood clot in leg since 3 years. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. It was reported that patient got HDV or got blood clot on his leg. He was on Xarelto for 3 years. On an unspecified date, patient experienced blood clot on his leg. On 29Jul2021, couple of hours after vaccination, the patient experienced feeling weak, muscle aches, fatigue, muscle weakness and No energy. No investigation assessment. Patient would like to know if he should receive the medical attention and how long this would last and he was still experiencing the side effects (at the time of report). The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
we had the shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles (Verbatim: we had the shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 16-Jun-2023 This case was reported the patient via interactive digital media. The patients got the shot, and two weeks later had the shingles, never again the patient would receive one. Follow-up not possible as no contact details provided. This case has been linked with case US2023AMR085308 reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR085308:same reporter
Crying (loud high-pitched)for 4 hours, swollen left thigh. Parent gave Tylenol 0.6ml at 1430 for temp of 101.5.
Rash developed 2 days after ActHib vaccine was given, could have been due to vaccine vs. URI that developed after had vaccine given.  No prior reaction to this vaccine.
Headache; High Fever; Sore Muscles; Loss of appetite; Weakness; This is a spontaneous report from a non-contactable pharmacist, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and allergy to seafood. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C), zinc (MANUFACTURER UNKNOWN) and sitosterol (CHOLESTOFF); all for unknown indications from unknown dates and unknown if ongoing. On 10Apr2021, the patient experienced headache, high fever, sore muscles, loss of appetite and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with paracetamol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, high fever, sore muscles, loss of appetite and weakness was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fatigue; Sore upper arm at injection site; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 5 year-old female patient received bnt162b2 (BNT162B2), administration date 14Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 14Apr2021, outcome "unknown", described as "Fatigue"; VACCINATION SITE PAIN (non-serious) with onset 14Apr2021, outcome "unknown", described as "Sore upper arm at injection site". Therapeutic measures were not taken as a result of fatigue, vaccination site pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain between shoulder blades night of vaccine  Discomfort left upper neck - Tylenol taken for pain  "swollen lymh" left side neck day after injection  notified Supervisor
Case previously recorded as MA2009-4586. Initial case report received from a physician on 17 NOV 2009. A patient 3-year-old or younger was vaccinated with FLUVIRIN 2009/2010 i.m. on 13 NOV 2009. No adverse effect was reported. Reference no: NA09-008308.
second shot 7 months after the first vaccine; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 8th April 2019).   On 30th November 2019, the patient received the 2nd dose of Shingrix. On 30th November 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received second Shingrix shot approximately 7 months after she received the first vaccine, which led to lengthening of vaccination schedule. The patient did not know the lot number or expiration date of the vaccine. The reporter did not consent to follow up.
Client vaccinated with Pfizer vaccines for Covid on 3/20 and 4/20/2021.  Developed symptoms of Covid on 11/9 - nasal congestion, cough, headache, myalgia, sore throat, fever.  Tested + for Covid with PCR on 11/11.  Reported as a case of breakthrough Covid illness.
Bradycardia. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Suffering from the results, especially in the Left leg; Initial information was received on 03-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient of (unknown demographics) who was experienced suffering from the results, especially in the left leg (limb discomfort), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious suffering from the results, especially in the left leg (limb discomfort) (unknown latency) following the administration of INFLUENZA VACCINE.  There were no laboratory data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
head cold; Runny nose; cough; I was tested positive Thursday 31Mar2022 I started your medicine on Saturday.; I was tested positive Thursday 31Mar2022 I started your medicine on Saturday.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), in Oct2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 31Mar2022, outcome "unknown" and all described as "I was tested positive Thursday 31Mar2022 I started your medicine on Saturday."; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "head cold"; RHINORRHOEA (non-serious), outcome "unknown", described as "Runny nose"; COUGH (non-serious), outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (31Mar2022) Positive. Therapeutic measures were taken as a result of covid-19, nasopharyngitis, rhinorrhoea, cough. The patient reported that today is my last day to take Paxlovid. I was tested positive Thursday 31Mar2022 I started your medicine on Saturday. My only symptoms have been a head cold runny nose and a cough no fever. I had my booster vaccination in October how long do I have to wait to get the fourth booster that is now available. Also do you know how long I will still be tested positive even though I no longer have the virus.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After 12 hrs. neuropathy in feet and torso, shortness of breath, chest tightness continued for 3 days went to urgent care checked out OK but symptoms persist to this day. On 3/13 severe dizziness and vomiting and blacking out and went to ER. Admitted overnight.  Pulmonologist prescribed course of Prednisone on 3/15 and ending on 3/25. Some relief for chest tightness  Neuropathy has gotten steadily worse with  inclusion of face and lower leg.  On 4th day began some ringing in ears which is to this day louder. Have fatiugue, sleep issues, trouble focusing  my brain and eyes. Everything is worse today. Can't hold my head up. Will someone please help me
Information has been received from a consumer concerning his 74 year old wife with diabetes and no drug reactions or allergies, who on 04-AUG-2008 was vaccinated once with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot# unknown). The consumer's husband reported that his wife was given ZOSTAVAX (Merck) but on 22-SEP-2010 she developed shingles anyway. There were no laboratory tests or diagnostic studies performed. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
Eczema, worst breakout ever. Big red patches of blisters and pus. Took several days to clear with topical medications.
Local erythema and  itching started today . No treatment needed at this time. Plan to observe
Patient had her 1st vaccine on 4/22 and on 4/23 had the hives and was sick. Patient had her 2nd vaccine on 5/20 and on that day had lots of pain and was tired.
Patient reports suddenly feeling tired and having "brain fog" and saying incorrect words. Instructed patient to lay down. VS at 1113 were BP 126/82, P 73, O2 100% on RA, and no pain. Patient reports having tiredness with her first dose. Patient denies any other symptoms. After 30 minutes patient reports feeling improved and no new symptoms. Instructed patient to arrange for a ride home and to rest. Instructed patient to seek medical help if symptoms worsen or new symptoms occur.
Approximately 10 hours after vaccination I developed sudden onset of fatigue, severe headache, lightheadedness, cyclical chills, tachycardia, bilateral conjunctival erythema, excessive tears and muscle spasm which lasted for about 4hours
pressure in middle of chest. had to breath deep to get air. felt uneasy. heart rate up over 80. blood pressure 143
Went to sleep /p shot & was hard to arouse, limp for 2 hrs, which is not normally how he is when he is asleep, normally easily aroused.
my joints that are affected, my legs and from groin down to my toes; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 21Jan2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer (patient). This female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 18Jan2021, the patient was experiencing side effects. She stated that her husband will have to take her to the emergency room tomorrow if it stays the same. It's her joints that are affected, her legs and from groin down to her toes. This happened shortly after she received the vaccine, it happened around 2 days later. Outcome of the event was unknown.  Information about lot/batch number has been requested.
Tinnitus!  My ears started ringing shortly after my last booster and have never stopped.
Fever, chills, extreme fatigue, general malaise, extreme weakness, nausea, loss of appetite, headache, body aches all over.  I became ill the night I took the shot.  I stayed in bed for 36 hours without eating and could not work.  I was totally exhausted.  After the 36 hours, I slowly recovered.  I had received the shot (first dose of Moderna) on Thursday at about Noon.  I was not able to return to work until Monday afternoon, and it was very limited on Monday.  (I own my own business and had canceled work and clients and office work).  I was back to about 75 % normal capacity to work on Tuesday, and close to 100 % on Wednesday.
Client was given a flu vaccine at 10:00 AM. Client started having a seizure at 10:01. Called EMS at 10:02. Client was stable when left with EMS.
Pt had about 10 episodes of vomiting in a 3 hour period.  Tolerating no fluid, and it became bilious towards the end.
tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable consumer (the patient). This adult non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an intramuscular route of administration on 02Mar2021 (Lot Number: UNKNOWN) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an intramuscular route of administration on 23Mar2021 (Lot Number: UNKNOWN), both as single dose for COVID-19 immunization. Medical history included hypercholesterolemia, arthritis and premature ventricular contractions. The patient has no known allergies. The patient did receive other unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. After the second vaccination received on 23Mar2021, the patient tested positive for COVID-19 on 17Jul2021 which resulted in a visit to the doctor or other healthcare professional office/clinic. No treatment was received for the adverse event(s). The clinical outcome of the event(s) "tested positive for COVID-19" was reported as resolved on an unspecified date in 2021.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.